Edson X. Albuquerque - Publications

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 

157 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hahn B, Shrieves ME, Olmstead CK, Yuille MB, Chiappelli JJ, Pereira EFR, Albuquerque EX, Fawcett WP. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects. Psychopharmacology. PMID 31686175 DOI: 10.1007/S00213-019-05363-4  0.393
2019 Lumsden EW, Troppoli TA, Myers SJ, Zanos P, Aracava Y, Kehr J, Lovett J, Kim S, Wang FH, Schmidt S, Jenne CE, Yuan P, Morris PJ, Thomas CJ, Zarate CA, ... ... Albuquerque EX, et al. Antidepressant-relevant concentrations of the ketamine metabolite (2,6)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America. PMID 30796190 DOI: 10.1073/Pnas.1816071116  0.357
2018 Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA, Gould TD. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews. 70: 621-660. PMID 29945898 DOI: 10.1124/Pr.117.015198  0.34
2015 Alkondon M, Pereira EF, Todd SW, Randall WR, Lane MV, Albuquerque EX. Functional G-protein-coupled receptor 35 is expressed by neurons in the CA1 field of the hippocampus. Biochemical Pharmacology. 93: 506-18. PMID 25542997 DOI: 10.1016/j.bcp.2014.12.009  0.361
2013 Banerjee J, Alkondon M, Albuquerque EX, Pereira EF. Contribution of CA3 and CA1 pyramidal neurons to the tonic α7 nAChR-dependent glutamatergic input to CA1 pyramidal neurons. Neuroscience Letters. 554: 167-71. PMID 23973303 DOI: 10.1016/j.neulet.2013.08.025  0.316
2013 Alkondon M, Albuquerque EX, Pereira EF. Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices. Neurotoxicology. 36: 72-81. PMID 23511125 DOI: 10.1016/j.neuro.2013.02.005  0.411
2013 Albuquerque EX, Schwarcz R. Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges. Biochemical Pharmacology. 85: 1027-32. PMID 23270993 DOI: 10.1016/j.bcp.2012.12.014  0.448
2012 Banerjee J, Alkondon M, Pereira EF, Albuquerque EX. Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid. The Journal of Pharmacology and Experimental Therapeutics. 341: 500-9. PMID 22344459 DOI: 10.1124/jpet.111.189860  0.425
2011 Mamczarz J, Kulkarni GS, Pereira EF, Albuquerque EX. Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance. Neurotoxicology. 32: 785-98. PMID 21784098 DOI: 10.1016/J.Neuro.2011.07.001  0.481
2011 Alkondon M, Pereira EF, Albuquerque EX. Endogenous activation of nAChRs and NMDA receptors contributes to the excitability of CA1 stratum radiatum interneurons in rat hippocampal slices: effects of kynurenic acid. Biochemical Pharmacology. 82: 842-51. PMID 21689641 DOI: 10.1016/j.bcp.2011.06.004  0.428
2011 Alkondon M, Pereira EF, Eisenberg HM, Kajii Y, Schwarcz R, Albuquerque EX. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain. The Journal of Pharmacology and Experimental Therapeutics. 337: 572-82. PMID 21270133 DOI: 10.1124/jpet.110.177386  0.419
2010 Ludwig J, Höffle-Maas A, Samochocki M, Luttmann E, Albuquerque EX, Fels G, Maelicke A. Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain. Journal of Receptor and Signal Transduction Research. 30: 469-83. PMID 21062106 DOI: 10.3109/10799893.2010.505239  0.592
2010 Alexandrova EA, Aracava Y, Pereira EF, Albuquerque EX. Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 334: 1051-8. PMID 20554906 DOI: 10.1124/jpet.110.167700  0.325
2010 Potter MC, Elmer GI, Bergeron R, Albuquerque EX, Guidetti P, Wu HQ, Schwarcz R. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1734-42. PMID 20336058 DOI: 10.1038/npp.2010.39  0.348
2010 Wu HQ, Pereira EF, Bruno JP, Pellicciari R, Albuquerque EX, Schwarcz R. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. Journal of Molecular Neuroscience : Mn. 40: 204-10. PMID 19690987 DOI: 10.1007/S12031-009-9235-2  0.368
2009 Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological Reviews. 89: 73-120. PMID 19126755 DOI: 10.1152/physrev.00015.2008  0.473
2009 Alkondon M, Aracava Y, Pereira EF, Albuquerque EX. A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 328: 69-82. PMID 18842705 DOI: 10.1124/jpet.108.146068  0.418
2007 Alkondon M, Pereira EF, Albuquerque EX. Age-dependent changes in the functional expression of two nicotinic receptor subtypes in CA1 stratum radiatum interneurons in the rat hippocampus. Biochemical Pharmacology. 74: 1134-44. PMID 17645875 DOI: 10.1016/j.bcp.2007.06.023  0.409
2007 Lopes C, Pereira EF, Wu HQ, Purushottamachar P, Njar V, Schwarcz R, Albuquerque EX. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 322: 48-58. PMID 17446300 DOI: 10.1124/Jpet.107.123109  0.46
2007 Alkondon M, Pereira EF, Potter MC, Kauffman FC, Schwarcz R, Albuquerque EX. Strain-specific nicotinic modulation of glutamatergic transmission in the CA1 field of the rat hippocampus: August Copenhagen Irish versus Sprague-Dawley. Journal of Neurophysiology. 97: 1163-70. PMID 17151218 DOI: 10.1152/Jn.01119.2006  0.403
2006 Popa RV, Pereira EF, Lopes C, Maelicke A, Albuquerque EX. The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 30: 227-32. PMID 17192682 DOI: 10.1385/JMN:30:1:227  0.578
2006 Santos HR, Ribeiro HS, Setti-Perdigão P, Albuquerque EX, Castro NG. The magnitude of alpha7 nicotinic receptor currents in rat hippocampal neurons is dependent upon GABAergic activity and depolarization. The Journal of Pharmacology and Experimental Therapeutics. 319: 376-85. PMID 16837558 DOI: 10.1124/Jpet.106.106385  0.441
2005 Banerjee P, Samoriski G, Gupta S, Aracava Y, Pereira EFR, Maelicke A, Albuquerque EX. Comments on "memantine blocks α7* nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons" (multiple letters) Journal of Pharmacology and Experimental Therapeutics. 313: 928-933. PMID 15831445 DOI: 10.1124/jpet.104.081976  0.315
2005 Aracava Y, Pereira EF, Maelicke A, Albuquerque EX. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics. 312: 1195-205. PMID 15522999 DOI: 10.1124/jpet.104.077172  0.659
2005 Rassoulpour A, Wu HQ, Albuquerque EX, Schwarcz R. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 697-704. PMID 15496939 DOI: 10.1038/sj.npp.1300583  0.369
2005 Aracava Y, Pereira EFR, Maelicke A, Albuquerque EX. Response: Comments on “Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-d-aspartate Receptors in Rat Hippocampal Neurons” Journal of Pharmacology and Experimental Therapeutics. 313: 930-933. DOI: 10.1124/jpet.104.082222  0.589
2004 Braga MF, Pereira EF, Mike A, Albuquerque EX. Pb2+ via protein kinase C inhibits nicotinic cholinergic modulation of synaptic transmission in the hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 311: 700-10. PMID 15226386 DOI: 10.1124/jpet.104.070466  0.674
2004 Alkondon M, Pereira EF, Yu P, Arruda EZ, Almeida LE, Guidetti P, Fawcett WP, Sapko MT, Randall WR, Schwarcz R, Tagle DA, Albuquerque EX. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4635-48. PMID 15140935 DOI: 10.1523/Jneurosci.5631-03.2004  0.633
2004 Almeida LE, Pereira EF, Camara AL, Maelicke A, Albuquerque EX. Sensitivity of neuronal nicotinic acetylcholine receptors to the opiate antagonists naltrexone and naloxone: receptor blockade and up-regulation. Bioorganic & Medicinal Chemistry Letters. 14: 1879-87. PMID 15050620 DOI: 10.1016/j.bmcl.2004.01.004  0.741
2004 Santos HR, Cintra WM, Aracava Y, Maciel CM, Castro NG, Albuquerque EX. Spine density and dendritic branching pattern of hippocampal CA1 pyramidal neurons in neonatal rats chronically exposed to the organophosphate paraoxon. Neurotoxicology. 25: 481-94. PMID 15019311 DOI: 10.1016/J.Neuro.2004.01.007  0.334
2004 Popa RV, Pereira EF, Maelicke A, Albuquerque EX. P1-417 Differential effects of galantaminone and galantamine N-butylcarbamate on α7 nicotinic acetylcholine receptors in hippocampal neurons Neurobiology of Aging. 25: S217. DOI: 10.1016/S0197-4580(04)80729-2  0.633
2004 Aracava Y, Pereira EF, Maelicke A, Albuquerque EX. P1-416 Memantine at clinically relevant concentrations blocks more potently α7 nicotinic than NMDA receptors: implications for treatment of Alzheimer's disease Neurobiology of Aging. 25: S217. DOI: 10.1016/S0197-4580(04)80728-0  0.613
2003 Menegatti R, Cunha AC, Ferreira VF, Perreira EF, El-Nabawi A, Eldefrawi AT, Albuquerque EX, Neves G, Rates SM, Fraga CA, Barreiro EJ. Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands. Bioorganic & Medicinal Chemistry. 11: 4807-13. PMID 14556797 DOI: 10.1016/S0968-0896(03)00487-5  0.329
2003 Alkondon M, Pereira EF, Albuquerque EX. NMDA and AMPA receptors contribute to the nicotinic cholinergic excitation of CA1 interneurons in the rat hippocampus. Journal of Neurophysiology. 90: 1613-25. PMID 12702709 DOI: 10.1152/jn.00214.2003  0.474
2003 Samochocki M, Höffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EF, Lübbert H, Albuquerque EX, Maelicke A. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. The Journal of Pharmacology and Experimental Therapeutics. 305: 1024-36. PMID 12649296 DOI: 10.1124/jpet.102.045773  0.66
2003 Santos MD, Pereira EF, Aracava Y, Castro NG, Fawcett WP, Randall WR, Albuquerque EX. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 304: 254-65. PMID 12490599 DOI: 10.1124/Jpet.102.043109  0.406
2003 Schwarcz R, Pereira E, Alkondon M, Almeida L, Fawcett W, Randall W, Guidetti P, Sapko M, Yu P, Tagle D, Albuquerque E. S.12.03 Physiological regulation of α7 nicotinic receptor activity by endogenous levels of the brain metabolite kynurenic acid: Clinical implications European Neuropsychopharmacology. 13: S128. DOI: 10.1016/S0924-977X(03)91647-6  0.561
2002 Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX. Unconventional ligands and modulators of nicotinic receptors. Journal of Neurobiology. 53: 479-500. PMID 12436414 DOI: 10.1002/neu.10146  0.648
2002 Santos MD, Alkondon M, Pereira EF, Aracava Y, Eisenberg HM, Maelicke A, Albuquerque EX. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Molecular Pharmacology. 61: 1222-34. PMID 11961141 DOI: 10.1124/mol.61.5.1222  0.653
2001 Wang Y, Pereira EF, Maus AD, Ostlie NS, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM. Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Molecular Pharmacology. 60: 1201-9. PMID 11723227 DOI: 10.1124/Mol.60.6.1201  0.399
2001 Albuquerque EX, Santos MD, Alkondon M, Pereira EF, Maelicke A. Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Disease and Associated Disorders. 15: S19-25. PMID 11669505 DOI: 10.1097/00002093-200108001-00004  0.65
2001 Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 7463-73. PMID 11567036  0.367
2001 Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig J, Albuquerque EX, Zerlin M. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biological Psychiatry. 49: 279-88. PMID 11230879 DOI: 10.1016/S0006-3223(00)01109-4  0.619
2000 Samochocki M, Zerlin M, Jostock R, Groot Kormelink PJ, Luyten WH, Albuquerque EX, Maelicke A. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. Acta Neurologica Scandinavica. Supplementum. 176: 68-73. PMID 11261808 DOI: 10.1034/j.1600-0404.2000.00310.x  0.64
2000 Mike A, Castro NG, Albuquerque EX. Choline and acetylcholine have similar kinetic properties of activation and desensitization on the alpha7 nicotinic receptors in rat hippocampal neurons. Brain Research. 882: 155-68. PMID 11056195 DOI: 10.1016/S0006-8993(00)02863-8  0.475
2000 Almeida LE, Pereira EF, Alkondon M, Fawcett WP, Randall WR, Albuquerque EX. The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs. Neuropharmacology. 39: 2740-55. PMID 11044744 DOI: 10.1016/S0028-3908(00)00157-X  0.656
2000 Alkondon M, Pereira EF, Almeida LE, Randall WR, Albuquerque EX. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology. 39: 2726-39. PMID 11044743 DOI: 10.1016/S0028-3908(00)00156-8  0.655
2000 Maelicke A, Schrattenholz A, Samochocki M, Radina M, Albuquerque EX. Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behavioural Brain Research. 113: 199-206. PMID 10942046 DOI: 10.1016/S0166-4328(00)00214-X  0.669
2000 Albuquerque EX, Pereira EF, Mike A, Eisenberg HM, Maelicke A, Alkondon M. Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance. Behavioural Brain Research. 113: 131-41. PMID 10942040 DOI: 10.1016/S0166-4328(00)00208-4  0.66
2000 Maelicke A, Albuquerque EX. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. European Journal of Pharmacology. 393: 165-70. PMID 10771010 DOI: 10.1016/S0014-2999(00)00093-5  0.652
2000 Alkondon M, Braga MF, Pereira EF, Maelicke A, Albuquerque EX. alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. European Journal of Pharmacology. 393: 59-67. PMID 10770998 DOI: 10.1016/S0014-2999(00)00006-6  0.773
2000 Albuquerque EX, Alkondon M, Pereira EF, Maelicke A. Galantamine: An allosterically potentiating ligand of nicotinic acetylcholine receptors Neurobiology of Aging. 21: 168-169. DOI: 10.1016/S0197-4580(00)82097-7  0.64
1999 Fischer U, Reinhardt S, Albuquerque EX, Maelicke A. Expression of functional alpha7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. The European Journal of Neuroscience. 11: 2856-64. PMID 10457182 DOI: 10.1046/j.1460-9568.1999.00703.x  0.627
1999 Wevers A, Monteggia L, Nowacki S, Bloch W, Schütz U, Lindstrom J, Pereira EF, Eisenberg H, Giacobini E, de Vos RA, Steur EN, Maelicke A, Albuquerque EX, Schröder H. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. The European Journal of Neuroscience. 11: 2551-65. PMID 10383644 DOI: 10.1046/J.1460-9568.1999.00676.X  0.611
1999 Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological Reviews. 51: 397-401. PMID 10353988  0.317
1999 Braga MF, Pereira EF, Albuquerque EX. Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain Research. 826: 22-34. PMID 10216193 DOI: 10.1016/S0006-8993(99)01194-4  0.59
1999 Braga MF, Pereira EF, Marchioro M, Albuquerque EX. Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Research. 826: 10-21. PMID 10216192 DOI: 10.1016/S0006-8993(99)01193-2  0.743
1998 Albuquerque EX, Pereira EF, Braga MF, Matsubayashi H, Alkondon M. Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine. Toxicology Letters. 102: 211-8. PMID 10022256 DOI: 10.1016/S0378-4274(98)00309-9  0.59
1998 Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, Macklin K, Cortes WS, Albuquerque EX, Conti-Fine BM. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Molecular Pharmacology. 54: 779-88. PMID 9804613 DOI: 10.1124/Mol.54.5.779  0.41
1998 Albuquerque EX, Pereira EF, Braga MF, Alkondon M. Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors. Journal of Physiology, Paris. 92: 309-16. PMID 9789829 DOI: 10.1016/S0928-4257(98)80039-9  0.59
1998 Matsubayashi H, Alkondon M, Pereira EF, Swanson KL, Albuquerque EX. Strychnine: a potent competitive antagonist of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics. 284: 904-13. PMID 9495848  0.328
1997 Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. The European Journal of Neuroscience. 9: 2734-42. PMID 9517478 DOI: 10.1111/j.1460-9568.1997.tb01702.x  0.663
1997 Matsubayashi H, Swanson KL, Albuquerque EX. Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics. 281: 834-44. PMID 9152392  0.331
1997 Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM, Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. The Journal of Pharmacology and Experimental Therapeutics. 280: 1117-36. PMID 9067295  0.321
1997 Albuquerque EX, Pereira EF, Alkondon M, Schrattenholz A, Maelicke A. Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity. Journal of Receptor and Signal Transduction Research. 17: 243-66. PMID 9029494 DOI: 10.3109/10799899709036607  0.645
1997 Maelicke A, Coban T, Storch A, Schrattenholz A, Pereira EF, Albuquerque EX. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists. Journal of Receptor and Signal Transduction Research. 17: 11-28. PMID 9029479 DOI: 10.3109/10799899709036592  0.66
1996 Albuquerque EX, Pereira EF, Bonfante-Cabarcas R, Marchioro M, Matsubayashi H, Alkondon M, Maelicke A. Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity. Progress in Brain Research. 109: 111-24. PMID 9009698 DOI: 10.1016/S0079-6123(08)62093-2  0.767
1996 Marchioro M, Swanson KL, Aracava Y, Albuquerque EX. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics. 279: 143-53. PMID 8858987  0.641
1996 Rocha ES, Swanson KL, Aracava Y, Goolsby JE, Maelicke A, Albuquerque EX. Paraoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics. 278: 1175-87. PMID 8819500  0.33
1996 Barbosa CT, Alkondon M, Aracava Y, Maelicke A, Albuquerque EX. Ligand-gated ion channels in acutely dissociated rat hippocampal neurons with long dendrites. Neuroscience Letters. 210: 177-80. PMID 8805124 DOI: 10.1016/0304-3940(96)12679-3  0.598
1996 Maelicke A, Albuquerque EX. New approach to drug therapy in Alzheimer's dementia Drug Discovery Today. 1: 53-59. DOI: 10.1016/1359-6446(96)89089-1  0.638
1995 Maelicke A, Schrattenholz A, Storch A, Schroder B, Gutbrod O, Methfessel C, Weber KH, Pereira EE, Alkondon M, Albuquerque EX. Noncompetitive agonism at nicotinic acetylcholine receptors; functional significance for CNS signal transduction. Journal of Receptor and Signal Transduction Research. 15: 333-53. PMID 8903949 DOI: 10.3109/10799899509045225  0.675
1995 Castro NG, Albuquerque EX. alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophysical Journal. 68: 516-24. PMID 7696505 DOI: 10.1016/S0006-3495(95)80213-4  0.425
1995 Albuquerque EX, Pereira EF, Castro NG, Alkondon M, Reinhardt S, Schröder H, Maelicke A. Nicotinic receptor function in the mammalian central nervous system. Annals of the New York Academy of Sciences. 757: 48-72. PMID 7611705 DOI: 10.1111/J.1749-6632.1995.Tb17464.X  0.662
1995 Grando SA, Horton RM, Pereira EF, Diethelm-Okita BM, George PM, Albuquerque EX, Conti-Fine BM. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. The Journal of Investigative Dermatology. 105: 774-81. PMID 7490471 DOI: 10.1111/1523-1747.Ep12325606  0.437
1995 Albuquerque EX, Pereira EFR, Castro NG, Alkondon M. Neuronal nicotinic receptors: Function, modulation and structure Seminars in the Neurosciences. 7: 91-101. DOI: 10.1006/Smns.1995.0011  0.429
1994 Schrattenholz A, Roth U, Schuhen A, Schäfer HJ, Godovac-Zimmermann J, Albuquerque EX, Maelicke A. Identification of purine binding sites on Torpedo acetylcholine receptor. Journal of Receptor Research. 14: 197-208. PMID 8083864 DOI: 10.3109/10799899409066031  0.592
1993 Thomas P, Stephens M, Wilkie G, Amar M, Lunt GG, Whiting P, Gallagher T, Pereira E, Alkondon M, Albuquerque EX. (+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. Journal of Neurochemistry. 60: 2308-11. PMID 8492133 DOI: 10.1111/J.1471-4159.1993.Tb03519.X  0.479
1993 Pereira EF, Alkondon M, Tano T, Castro NG, Fróes-Ferrão MM, Rozental R, Aronstam RS, Schrattenholz A, Maelicke A, Albuquerque EX. A novel agonist binding site on nicotinic acetylcholine receptors. Journal of Receptor Research. 13: 413-36. PMID 8450498 DOI: 10.3109/10799899309073670  0.648
1993 Maelicke A, Coban T, Schrattenholz A, Schröder B, Reinhardt-Maelicke S, Storch A, Godovac-Zimmermann J, Methfessel C, Pereira EF, Albuquerque EX. Physostigmine and neuromuscular transmission. Annals of the New York Academy of Sciences. 681: 140-54. PMID 8395146 DOI: 10.1111/J.1749-6632.1993.Tb22880.X  0.651
1993 Good JL, Khurana RK, Mayer RF, Cintra WM, Albuquerque EX. Pathophysiological studies of neuromuscular function in subacute organophosphate poisoning induced by phosmet. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 290-4. PMID 8384655 DOI: 10.1136/Jnnp.56.3.290  0.32
1993 Schrattenholz A, Godovac-Zimmermann J, Schäfer HJ, Albuquerque EX, Maelicke A. Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. European Journal of Biochemistry / Febs. 216: 671-7. PMID 8375401 DOI: 10.1111/J.1432-1033.1993.Tb18187.X  0.638
1993 Schrattenholz A, Coban T, Schröder B, Okonjo KO, Kuhlmann J, Pereira EF, Albuquerque EX, Maelicke A. Biochemical characterization of a novel channel-activating site on nicotinic acetylcholine receptors. Journal of Receptor Research. 13: 393-412. PMID 7680720 DOI: 10.3109/10799899309073669  0.607
1993 Castro NG, Albuquerque EX. Brief-lifetime, fast-inactivating ion channels account for the alpha-bungarotoxin-sensitive nicotinic response in hippocampal neurons. Neuroscience Letters. 164: 137-40. PMID 7512242 DOI: 10.1016/0304-3940(93)90876-M  0.437
1992 Alkondon M, Pereira EF, Wonnacott S, Albuquerque EX. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Molecular Pharmacology. 41: 802-8. PMID 1569927  0.356
1992 Adler M, Deshpande SS, Foster RE, Maxwell DM, Albuquerque EX. Effects of subacute pyridostigmine administration on mammalian skeletal muscle function. Journal of Applied Toxicology : Jat. 12: 25-33. PMID 1564249 DOI: 10.1002/jat.2550120107  0.305
1992 Wonnacott S, Swanson KL, Albuquerque EX, Huby NJ, Thompson P, Gallagher T. Homoanatoxin: a potent analogue of anatoxin-A. Biochemical Pharmacology. 43: 419-23. PMID 1540199 DOI: 10.1016/0006-2952(92)90558-Z  0.321
1991 Wonnacott S, Jackman S, Swanson KL, Rapoport H, Albuquerque EX. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites. The Journal of Pharmacology and Experimental Therapeutics. 259: 387-91. PMID 1920126  0.315
1991 Swanson KL, Aronstam RS, Wonnacott S, Rapoport H, Albuquerque EX. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. The Journal of Pharmacology and Experimental Therapeutics. 259: 377-86. PMID 1920124  0.341
1991 Reddy VK, Deshpande SS, Cintra WM, Scoble GT, Albuquerque EX. Effectiveness of oximes 2-PAM and HI-6 in recovery of muscle function depressed by organophosphate agents in the rat hemidiaphragm: an in vitro study. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 17: 746-60. PMID 1778361 DOI: 10.1093/toxsci/17.4.746  0.317
1991 Albuquerque EX, Costa AC, Alkondon M, Shaw KP, Ramoa AS, Aracava Y. Functional properties of the nicotinic and glutamatergic receptors. Journal of Receptor Research. 11: 603-25. PMID 1715922 DOI: 10.3109/10799899109066430  0.335
1990 Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacott S, Aronstam RS, Albuquerque EX. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. The Journal of Pharmacology and Experimental Therapeutics. 254: 71-82. PMID 1694895  0.354
1990 Costa AC, Swanson KL, Aracava Y, Aronstam RS, Albuquerque EX. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor. The Journal of Pharmacology and Experimental Therapeutics. 252: 507-16. PMID 1690291  0.355
1989 Rozental R, Aracava Y, Scoble GT, Swanson KL, Wonnacott S, Albuquerque EX. Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine. The Journal of Pharmacology and Experimental Therapeutics. 251: 395-404. PMID 2478693  0.33
1989 Rozental R, Scoble GT, Albuquerque EX, Idriss M, Sherby S, Sattelle DB, Nakanishi K, Konno K, Eldefrawi AT, Eldefrawi ME. Allosteric inhibition of nicotinic acetylcholine receptors of vertebrates and insects by philanthotoxin. The Journal of Pharmacology and Experimental Therapeutics. 249: 123-30. PMID 2468760  0.346
1988 Macallan DR, Lunt GG, Wonnacott S, Swanson KL, Rapoport H, Albuquerque EX. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. Febs Letters. 226: 357-63. PMID 3338564 DOI: 10.1016/0014-5793(88)81454-6  0.401
1988 Ramoa AS, Albuquerque EX. Phencyclidine and some of its analogues have distinct effects on NMDA receptors of rat hippocampal neurons. Febs Letters. 235: 156-62. PMID 2456947 DOI: 10.1016/0014-5793(88)81254-7  0.363
1987 Oliveira L, Madsen BW, Kapai N, Sherby SM, Swanson KL, Eldefrawi ME, Albuquerque EX. Interaction of narcotic antagonist naltrexone with nicotinic acetylcholine receptor. European Journal of Pharmacology. 140: 331-42. PMID 3653249 DOI: 10.1016/0014-2999(87)90290-1  0.448
1987 Aracava Y, Deshpande SS, Swanson KL, Rapoport H, Wonnacott S, Lunt G, Albuquerque EX. Nicotinic acetylcholine receptors in cultured neurons from the hippocampus and brain stem of the rat characterized by single channel recording. Febs Letters. 222: 63-70. PMID 2443390 DOI: 10.1016/0014-5793(87)80192-8  0.314
1987 Allen CN, Albuquerque EX. Conductance properties of GABA-activated chloride currents recorded from cultured hippocampal neurons. Brain Research. 410: 159-63. PMID 2438013 DOI: 10.1016/S0006-8993(87)80039-2  0.33
1987 Rapier C, Wonnacott S, Lunt GG, Albuquerque EX. The neurotoxin histrionicotoxin interacts with the putative ion channel of the nicotinic acetylcholine receptors in the central nervous system. Febs Letters. 212: 292-6. PMID 2434360 DOI: 10.1016/0014-5793(87)81363-7  0.475
1986 Aronstam RS, Daly JW, Spande TF, Narayanan TK, Albuquerque EX. Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochemical Research. 11: 1227-40. PMID 2431336 DOI: 10.1007/Bf00965950  0.372
1986 Albuquerque EX, Deshpande SS, Aracava Y, Alkondon M, Daly JW. A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor. A study with forskolin and its analogs. Febs Letters. 199: 113-20. PMID 2420646 DOI: 10.1016/0014-5793(86)81235-2  0.448
1986 Swanson KL, Allen CN, Aronstam RS, Rapoport H, Albuquerque EX. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Molecular Pharmacology. 29: 250-7. PMID 2419745  0.326
1986 Allen CN, Albuquerque EX. Characteristics of acetylcholine-activated channels of innervated and chronically denervated skeletal muscles. Experimental Neurology. 91: 532-45. PMID 2419153 DOI: 10.1016/0014-4886(86)90050-6  0.329
1986 Sherby SM, Eldefrawi AT, Deshpande SS, Albuquerque EX, Eldefrawi ME. Effects of pyrethroids on nicotinic acetylcholine receptor binding and function Pesticide Biochemistry and Physiology. 26: 107-115. DOI: 10.1016/0048-3575(86)90082-9  0.448
1985 Meshul CK, Boyne AF, Deshpande SS, Albuquerque EX. Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles. Experimental Neurology. 89: 96-114. PMID 4007120 DOI: 10.1016/0014-4886(85)90268-7  0.59
1985 Sherby SM, Eldefrawi AT, Albuquerque EX, Eldefrawi ME. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Molecular Pharmacology. 27: 343-8. PMID 3974572  0.343
1985 Shaw KP, Aracava Y, Akaike A, Daly JW, Rickett DL, Albuquerque EX. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Molecular Pharmacology. 28: 527-38. PMID 2417099  0.5
1985 Aronstam RS, King CT, Albuquerque EX, Daly JW, Feigl DM. Binding of [3H]perhydrohistrionicotoxin and [3H]phencyclidine to the nicotinic receptor-ion channel complex of Torpedo electroplax. Inhibition by histrionicotoxins and derivatives. Biochemical Pharmacology. 34: 3037-47. PMID 2412560 DOI: 10.1016/0006-2952(85)90145-5  0.305
1984 Souccar C, Varanda WA, Aronstam RS, Daly JW, Albuquerque EX. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization. Molecular Pharmacology. 25: 395-400. PMID 6328265  0.31
1984 Albuquerque EX, Akaike A, Shaw KP, Rickett DL. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 4: S27-33. PMID 6327444 DOI: 10.1016/0272-0590(84)90135-0  0.532
1984 Pascuzzo GJ, Akaike A, Maleque MA, Shaw KP, Aronstam RS, Rickett DL, Albuquerque EX. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Molecular Pharmacology. 25: 92-101. PMID 6323955  0.553
1984 Akaike A, Ikeda SR, Brookes N, Pascuzzo GJ, Rickett DL, Albuquerque EX. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies. Molecular Pharmacology. 25: 102-12. PMID 6323946  0.495
1984 Allen CN, Akaike A, Albuquerque EX. The frog interosseal muscle fiber as a new model for patch clamp studies of chemosensitive- and voltage-sensitive ion channels: actions of acetylcholine and batrachotoxin. Journal De Physiologie. 79: 338-43. PMID 6099417  0.441
1983 Carp JS, Aronstam RS, Witkop B, Albuquerque EX. Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proceedings of the National Academy of Sciences of the United States of America. 80: 310-4. PMID 6130531 DOI: 10.1073/Pnas.80.1.310  0.403
1982 Warnick JE, Jessup PJ, Overman LE, Eldefrawi ME, Nimit Y, Daly JW, Albuquerque EX. Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists. Molecular Pharmacology. 22: 565-73. PMID 6130469  0.301
1981 Guth L, Kemerer VF, Samaras TA, Warnick JE, Albuquerque EX. The roles of disuse and loss of neurotrophic function in denervation atrophy of skeletal muscle. Experimental Neurology. 73: 20-36. PMID 7250275 DOI: 10.1016/0014-4886(81)90042-X  0.331
1981 Schofield GG, Warnick JE, Albuquerque EX. Elucidation of the mechanism and site of action of quinuclidinyl benzilate (QNB) on the electrical excitability and chemosensitivity of the frog sartorius muscle. Cellular and Molecular Neurobiology. 1: 209-30. PMID 6980708 DOI: 10.1007/Bf00710720  0.398
1981 Brown GB, Tieszen SC, Daly JW, Warnick JE, Albuquerque EX. Batrachotoxinin-A 20-alpha-benzoate: a new radioactive ligand for voltage sensitive sodium channels. Cellular and Molecular Neurobiology. 1: 19-40. PMID 6286124 DOI: 10.1007/Bf00736037  0.34
1981 Albuquerque EX, Aguayo LG, Warnick JE, Weinstein H, Glick SD, Maayani S, Ickowicz RK, Blaustein MP. The behavioral effects of phencyclidines may be due to their blockade of potassium channels. Proceedings of the National Academy of Sciences of the United States of America. 78: 7792-6. PMID 6278489 DOI: 10.1073/Pnas.78.12.7792  0.381
1981 Schofield GG, Witkop B, Warnick JE, Albuquerque EX. Differentiation of the open and closed states of the ionic channels of nicotinic acetylcholine receptors by tricyclic antidepressants. Proceedings of the National Academy of Sciences of the United States of America. 78: 5240-4. PMID 6272297 DOI: 10.1073/Pnas.78.8.5240  0.41
1981 Eldefrawi ME, Warnick JE, Schofield GG, Albuquerque EX, Eldefrawi AT. Interaction of imipramine with the ionic channel of the acetylcholine receptor of motor endplate and electric organ. Biochemical Pharmacology. 30: 1391-4. PMID 6268097 DOI: 10.1016/0006-2952(81)90331-2  0.316
1980 Deshpande SS, Warnick JE, Guth L, Albuquerque EX. Quantal release of acetylcholine does not regulate the resting membrane potential of mammalian skeletal muscle: evidence from in vivo experiments. Experimental Neurology. 70: 122-37. PMID 7418764 DOI: 10.1016/0014-4886(80)90010-2  0.323
1980 Guth L, Richman E, Barrett C, Warnick JE, Albuquerque EX. The mechanism by which degenerating peripheral nerve produces extrajunctional acetylcholine sensitivity in mammalian skeletal muscle. Experimental Neurology. 68: 465-76. PMID 7379892 DOI: 10.1016/0014-4886(80)90101-6  0.322
1980 Eldefrawi ME, Eldefrawi AT, Aronstam RS, Maleque MA, Warnick JE, Albuquerque EX. [3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proceedings of the National Academy of Sciences of the United States of America. 77: 7458-62. PMID 6261260 DOI: 10.1073/Pnas.77.12.7458  0.391
1980 Daly JW, Myers CW, Warnick JE, Albuquerque EX. Levels of batrachotoxin and lack of sensitivity to its action in poison-dart frogs (Phyllobates). Science (New York, N.Y.). 208: 1383-5. PMID 6246586 DOI: 10.1126/Science.6246586  0.301
1978 Sarvey JM, Albuquerque EX, Eldefrawi AT, Eldefrawi M. Effects of alpha-bungarotoxin and reversible cholinergic ligands on normal and denervated mammalian skeletal muscle. Membrane Biochemistry. 1: 131-57. PMID 756485 DOI: 10.3109/09687687809064163  0.703
1978 Eldefrawi ME, Eldefrawi AT, Mansour NA, Daly JW, Witkop B, Albuquerque EX. Acetylcholine receptor and ionic channel of Torpedo electroplax: binding of perhydrohistrionicotoxin to membrane and solubilized preparations. Biochemistry. 17: 5474-84. PMID 728410 DOI: 10.1021/Bi00618A023  0.34
1978 Garcia JH, Deshpande SS, Pence RS, Albuquerque EX. Spinal myelopathy induced by subarachnoid batrachotoxin: ultrastructure and electrophysiology. Brain Research. 140: 75-87. PMID 626887 DOI: 10.1016/0006-8993(78)90239-1  0.335
1978 Albuquerque EX, Deshpande SS, Guth L. Physiological properties of the innervated and denervated neuromuscular junction of hibernating and nonhibernating ground squirrels. Experimental Neurology. 62: 347-73. PMID 215439 DOI: 10.1016/0014-4886(78)90061-4  0.343
1977 Dolly JO, Albuquerque EX, Sarvey J, Mallick B, Barnard EA. Binding of perhydro-histrionicotoxin to the postsynaptic membrane of skeletal muscle in relation to its blockage of acetylcholine-induced depolarization. Molecular Pharmacology. 13: 1-14. PMID 834179  0.667
1977 Eldefrawi AT, Eldefrawi ME, Albuquerque EX, Oliveira AC, Mansour N, Adler M, Daly JW, Brown GB, Burgermeister W, Witkop B. Perhydrohistrionicotoxin: a potential ligand for the ion conductance modulator of the acetylcholine receptor. Proceedings of the National Academy of Sciences of the United States of America. 74: 2172-6. PMID 301278 DOI: 10.1073/Pnas.74.5.2172  0.35
1977 Warnick JE, Albuquerque EX, Guth L. The demonstration of neurotrophic function by application of colchicine or vinblastine to the peripheral nerve. Experimental Neurology. 57: 622-36. PMID 20317 DOI: 10.1016/0014-4886(77)90094-2  0.34
1976 Kauffman FC, Albuquerque EX, Warnick JE, Max SR. Effect of vinblastine on neural regulation of metabolism in rat skeletal muscle. Experimental Neurology. 50: 60-6. PMID 1248546 DOI: 10.1016/0014-4886(76)90235-1  0.316
1976 Rash JE, Albuquerque EX, Hudson CS, Mayer RF, Satterfield JR. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex. Proceedings of the National Academy of Sciences of the United States of America. 73: 4584-8. PMID 1070009 DOI: 10.1073/Pnas.73.12.4584  0.353
1976 Deshpande SS, Albuquerque EX, Guth L. Neurotrophic regulation of prejunctional and postjunctional membrane at the mammalian motor endplate. Experimental Neurology. 53: 151-65. PMID 964335 DOI: 10.1016/0014-4886(76)90289-2  0.333
1976 Albuquerque EX, Rash JE, Mayer RF, Satterfield JR. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis. Experimental Neurology. 51: 536-63. PMID 179836 DOI: 10.1016/0014-4886(76)90179-5  0.325
1976 Lapa AJ, Albuquerque EX. The cholinergic receptor of innervated and chronically denervated mammalian skeletal muscles: an electrophysiological study General Pharmacology: Vascular System. 7: 206.  0.558
1975 McArdle JJ, Albuquerque EX. Effects of ouabain on denervated and dystrophic muscles of the mouse. Experimental Neurology. 47: 353-6. PMID 1140236 DOI: 10.1016/0014-4886(75)90263-0  0.305
1975 Lapa AJ, Albuquerque EX, Sarvey JM, Daly J, Witkop B. Effects of histrionicotoxin on the chemosensitive and electrical properties of skeletal muscle. Experimental Neurology. 47: 558-80. PMID 1132464 DOI: 10.1016/0014-4886(75)90088-6  0.763
1975 Barnard EA, Dolly JO, Porter CW, Albuquerque EX. The acetylcholine receptor and the ionic conductance modulation system of skeletal muscle. Experimental Neurology. 48: 1-28. PMID 165962 DOI: 10.1016/0014-4886(75)90219-8  0.316
1974 Lapa AJ, Albuquerque EX, Daly J. An electrophysiological study of the effects of D-tubocurarine, atropine, and alpha-bungarotoxin on the cholinergic receptor in innervated and chronically denervated mammalian skeletal muscles. Experimental Neurology. 43: 375-98. PMID 4826975 DOI: 10.1016/0014-4886(74)90179-4  0.558
1974 Albuquerque EX, Barnard EA, Porter CW, Warnick JE. The density of acetylcholine receptors and their sensitivity in the postsynaptic membrane of muscle endplates. Proceedings of the National Academy of Sciences of the United States of America. 71: 2818-22. PMID 4546945 DOI: 10.1073/Pnas.71.7.2818  0.416
1974 Chiu TH, Lapa AJ, Barnard EA, Albuquerque EX. Binding of D-tubocurarine and alpha-bungarotoxin in normal and denervated mouse muscles. Experimental Neurology. 43: 399-413. PMID 4363769 DOI: 10.1016/0014-4886(74)90180-0  0.599
1974 Sarvey JM, Albuquerque EX. Interaction of carbachol, hexamethonium and decamethonium with α bungarotoxin on innervated and denervated muscle Federation Proceedings. 33: I.  0.649
1973 Albuquerque EX, Barnard EA, Chiu TH, Lapa AJ, Dolly JO, Jansson SE, Daly J, Witkop B. Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions. Proceedings of the National Academy of Sciences of the United States of America. 70: 949-53. PMID 4351811 DOI: 10.1073/Pnas.70.3.949  0.688
1973 Sarvey JM, Lapa AJ, Albuquerque EX. Effect of α bungarotoxin on blockade of cholinergic receptors Pharmacologist. 15: 373.  0.763
1973 Lapa AJ, Albuquerque EX, Daly J, Witkop B. Effect of natural and semisynthetic analogs of histrionicotoxin on skeletal muscle Pharmacologist. 15: 93.  0.558
1972 Albuquerque EX, Sasa M, Sarvey JM. Batrachotoxin has no effect on the electrogenic membranes of lobster and crayfish muscles. Life Sciences. Pt. 1: Physiology and Pharmacology. 11: 357-63. PMID 4656856 DOI: 10.1016/0024-3205(72)90062-8  0.64
1969 Albuquerque EX, Chung SH, Ottoson D. The action of tetrodotoxin on the frog's isolated muscle spindle. Acta Physiologica Scandinavica. 75: 301-12. PMID 5790222 DOI: 10.1111/j.1748-1716.1969.tb04383.x  0.576
1968 Albuquerque EX, Thesleff S. A comparative study of membrane properties of innervated and chronically denervated fast and slow skeletal muscles of the rat. Acta Physiologica Scandinavica. 73: 471-80. PMID 5708174 DOI: 10.1111/J.1365-201X.1968.Tb10886.X  0.494
1968 Albuquerque EX, Sokoll MD, Sonesson B, Thesleff S. Studies on the nature of the cholinergic receptor. European Journal of Pharmacology. 4: 40-6. PMID 5680369 DOI: 10.1016/0014-2999(68)90007-1  0.494
1968 Albuquerque EX, Thesleff S. The effect of calcium on the skeletal muscle membrane after treatment with phospholipase C. Acta Physiologica Scandinavica. 72: 310-21. PMID 5659744 DOI: 10.1111/j.1748-1716.1968.tb03846.x  0.494
1968 Albuquerque EX, Thesleff S. Effects of phospholipase A and lysolecithin on some electrical properties of the muscle membrane. Acta Physiologica Scandinavica. 72: 248-52. PMID 5655757 DOI: 10.1111/j.1748-1716.1968.tb03852.x  0.494
1967 Albuquerque EX, Thesleff S. Influence of phospholipase C on some electrical properties of the skeletal muscle membrane. The Journal of Physiology. 190: 123-37. PMID 6038015 DOI: 10.1113/jphysiol.1967.sp008197  0.494
1967 Thesleff S, Albuquerque EX. THE CHOLINERGIC RECEPTOR SYSTEMS OF DENERVATED STRIATED MUSCLE AND THEIR INTEGRATION WITH PHOSPHOLIPID MOLECULES. Annals of the New York Academy of Sciences. 144: 534-542. DOI: 10.1111/j.1749-6632.1967.tb53792.x  0.494
Show low-probability matches.